Back
LSB Industries 10K Form
Sell
45
LXU
LSB Industries
Last Price:
8.47
Seasonality Move:
1.21%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-02 | 10Q | LXU/LSB Industries Quarterly |
| 2023-07-27 | 10Q | LXU/LSB Industries Quarterly |
| 2023-05-03 | 10Q | LXU/LSB Industries Quarterly |
| 2022-11-02 | 10Q | LXU/LSB Industries Quarterly |
| 2022-07-28 | 10Q | LXU/LSB Industries Quarterly |
| 2022-05-04 | 10Q | LXU/LSB Industries Quarterly |
Receive LXU News And Ratings
See the #1 stock for the next 7 days that we like better than LXU
LXU Financial Statistics
Sales & Book Value
| Annual Sales: | $593.71M |
|---|---|
| Cash Flow: | $-9.48M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $7.17 |
| Price / Book: | 1.3 |
Profitability
| EPS (TTM): | 0.24000 |
|---|---|
| Net Income (TTM): | $17.65M |
| Gross Margin: | $86.26M |
| Return on Equity: | 3.34% |
| Return on Assets: | 1.34% |
LSB Industries Earnings Forecast
Key LSB Industries Financial Ratios
- The Gross Profit Margin over the past 40 years for LXU is 14.53%.
- The Selling, General & Administrative Expenses for LXU have been equal to 6.16% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 147.32% of Operating Income.
- The Net Earning history of LXU is 4.70% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 19 years.
LSB Industries Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Chemicals |
| Sector: | Materials |
| Current Symbol: | LXU |
| CUSIP: | 502160 |
| Website: | lsbindustries.com |
Debt
| Debt-to-Equity Ratio: | 1.08 |
|---|---|
| Current Ratio: | 3.64 |
| Quick Ratio: | 2.91 |
Price-to-Earnings
| Trailing P/E Ratio: | 25.14 |
|---|---|
| Forward P/E Ratio: | 25.9 |
LXU Technical Analysis vs Fundamental Analysis
Sell
45
LSB Industries (LXU)
is a Sell
Is LSB Industries a Buy or a Sell?
-
LSB Industries stock is rated a Sell
The current LSB Industries [LXU] share price is $9.30. The Score for LXU is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.